Improve the quality of patients lives
Improve the quality of patients lives
Soma BioTherapeutics is focused on providing support to scientist and innovators with technologies and products that can improve the lives of suffering patients.
Soma Biotherapeutics is focused on the development of innovative technology platforms designed to achieve effective and safe treatment for patients suffering with serious diseases such as cancer and neurodegenerative.
Bring your technology or product or idea to Soma Biotherapeutics. Our team of expert professional will walk it through funding cycle, process development, GMP manufacturing to clinical trials to commercialization.
SBT is uniquely positioned to create value proportion for your technology and/or therapeutic product to advance new medicines for suffering patients.
SBT Scientific Advisory team with a successful track record spans the wide spectrum of scientific fields, from discovery to global commercialization.
Exclusive worldwide license for research, development, manufacture and commercialization of Centyrin protein therapeutics.
SBT has a robust model of translating the lab developed technologies to clinic drives that incorporates different aspects of translation in compliance with regulations and policies globally.
Soma Biotherapeutics is harnessing its scientific leadership and panel of expert advisors to guide the development of therapeutic platform.
Our lead therapeutic technology, currently in discovery stage can be applied to treat broad spectrum of diseases.
This first-of-its-kind approach addresses unmet medical needs by allowing controlled dose of drug at targeted site of disease avoiding the non-target organs.
SBT believes that through precise targeting of drug, the potential to deliver and efficacy to treat diseases is more efficient.
Monday - Friday: 8:00am - 5:00pm
Saturday - Sunday: Closed
Copyright © 2024 Soma BioTherapeutics - All Rights Reserved.
Powered by GoDaddy